These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24722054)

  • 41. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
    Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.
    Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
    Radiother Oncol; 2009 Sep; 92(3):353-61. PubMed ID: 19699546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma.
    Jung HJ; Chen Z; Fayad L; Wang M; Romaguera J; Kwak LW; McCarty N
    Exp Hematol; 2012 Feb; 40(2):107-18.e2. PubMed ID: 22024108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
    Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma.
    Patel GK; Yee CL; Terunuma A; Telford WG; Voong N; Yuspa SH; Vogel JC
    J Invest Dermatol; 2012 Feb; 132(2):401-9. PubMed ID: 22011906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
    Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
    Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY; Schwartz BE; Hsu MY
    Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.
    Lee YY; Yang YP; Huang MC; Wang ML; Yen SH; Huang PI; Chen YW; Chiou SH; Lan YT; Ma HI; Shih YH; Chen MT
    Cell Transplant; 2014; 23(4-5):669-90. PubMed ID: 24816458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High CD133 expression levels in gastrointestinal stromal tumors.
    Bozzi F; Conca E; Manenti G; Negri T; Brich S; Gronchi A; Pierotti MA; Tamborini E; Pilotti S
    Cytometry B Clin Cytom; 2011; 80(4):238-47. PubMed ID: 21462307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells.
    Chen Y; Yu D; Zhang H; He H; Zhang C; Zhao W; Shao RG
    Int J Biol Sci; 2012; 8(7):992-1004. PubMed ID: 22904667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A minority subpopulation of CD133(+) /EGFRvIII(+) /EGFR(-) cells acquires stemness and contributes to gefitinib resistance.
    Liu XJ; Wu WT; Wu WH; Yin F; Ma SH; Qin JZ; Liu XX; Liu YN; Zhang XY; Li P; Han S; Liu KY; Zhang JM; He QH; Shen L
    CNS Neurosci Ther; 2013 Jul; 19(7):494-502. PubMed ID: 23575351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
    Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
    J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overactivation of Ras signaling pathway in CD133+ MPNST cells.
    Borrego-Diaz E; Terai K; Lialyte K; Wise AL; Esfandyari T; Behbod F; Mautner VF; Spyra M; Taylor S; Parada LF; Upadhyaya M; Farassati F
    J Neurooncol; 2012 Jul; 108(3):423-34. PubMed ID: 22484909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
    Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
    Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
    Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources.
    Radtke S; Haworth KG; Kiem HP
    Exp Hematol; 2016 Jun; 44(6):502-7. PubMed ID: 27016273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.